top of page

2nd Annual Research Symposium

October 2018


Jean-Frederic Colombel MD

The Mount Sinai Hospital

Key Note Address:

The Spirit of Collaboration: From GETAID to NYCCO


Jordan Axelrad MD

NYU Langone Medical Center

Risk of New or Recurrent Cancer in Patients With IBD and Previous Cancer


Galen Leung MD

Stonybrook University Medical Center

Managing Infliximab Re-introduction after Temporary Discontinuation of Drug: a Retrospective Multicentric Study

Keith Sultan.JPG

Keith Sultan MD

Northwell Health

Utilization  of Serologic and Genetic Testing in the Diagnosis and Management of  IBD: A Physician Survey

Robert Hirten 2.JPG

Robert Hirten MD

The Mount Sinai Hospital

Anastomotic Ulcers After Ileocolic Resection Predict Crohn's Disease Recurrence

Ryan Ungaro.JPG

Ryan Ungaro MD

The Mount Sinai Hospital

Stopping 5-Aminosalicylates in IBD Patients Starting Biologic Therapy Does Not Increase the Risk of Adverse Clinical Outcomes: Analysis of Two Nationwide of Population-Based Cohorts


Adam Tepler MD

Montefiore Medical Center

The Impact of Delay in Clostridium difficile Testing on Outcomes in IBD Patients Hospitalized with Gastrointestinal Symptoms


Qin Rao MD

Stonybrook University Medical Center

A Study of the Risk Factors for Hospital Admissions in IBD and the Differences between Crohn’s Disease and Ulcerative Colitis Admissions in a Large Tertiary Care Center

bottom of page